Arno Therapeutics, Inc. (OTC MKTS: ARNI) is a clinical stage biopharmaceutical company working to develop innovative products and next generation solutions for the treatment of cancer and other life threatening diseases. The company currently has exclusive worldwide rights to develop and market three innovative anti-cancer product candidates, all of which are currently in clinical or preclinical development as product candidates to treat hematologic malignancies and solid tumors. For more information, visit the company’s website at www.arnothera.com.

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its tenth annual equity conference in Sandpiper Bay, FL. Attended by institutional investors from across North America, the event features more than 140 public company executive teams from a diverse range of industries. For more information, visit www.noble.missionir.com.